Hudson Bay Capital Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Hudson Bay Capital Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-500,000	Closed	-$6.65K	–	1059
2023 Q2	$6.65K	Hold	500,000	–	–	﹤0.01%	778
2023 Q1	$25.5K	Hold	500,000	–	–	﹤0.01%	721
2022 Q4	$40.5K	Hold	500,000	–	–	﹤0.01%	783
2022 Q3	$103K	Hold	500,000	–	–	﹤0.01%	939
2022 Q2	$113K	Hold	500,000	–	–	﹤0.01%	1027
2022 Q1	$385K	Hold	500,000	–	–	0.01%	889
2021 Q4	$600K	Hold	500,000	–	–	0.01%	845
2021 Q3	$505K	Hold	500,000	–	–	0.01%	815
2021 Q2	$545K	Hold	500,000	–	–	0.01%	787
2021 Q1	$435K	Buy	+500,000	New	+$521K	0.01%	745

Hudson Bay Capital Management's GRNAW Position: Q3 2023 in Review

Hudson Bay Capital Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 500,000 shares — an estimated $6.65K sold.

Hudson Bay Capital Management first reported a position in GRNAW in Q1 2021 and held it in 10 quarters. The position peaked at $600K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

Hudson Bay Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 500,000 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $6.65K.
Hudson Bay Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 10 quarters.
Hudson Bay Capital Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $600K in Q4 2021.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Hudson Bay Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.